Malaria recombinant poxvirus vaccine
US6214353A · kind A · utility
15Cited by
3References
8Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 21, 1998 |
| Grant date | Apr 10, 2001 |
| Priority date | — |
| Expiry date | May 21, 2018 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
What is described is a recombinant poxvirus, such as vaccinia virus, containing foreign DNA from Plasmodium Merozoite Surface Antigen 1. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.